Infraredx yesterday registered for an initial public offering with the Securities & Exchange Commission, estimating the flotation’s worth at $55 million.
Burlington, Mass.-based Infraredx makes an imaging system that combines intravascular ultrasound and near-infrared spectroscopy to provide images of the interior of coronary blood vessels.
The company says the device is designed to detect lipid-core-containing plaque, which it says is implicated in higher risk for heart attack or stroke.
Infraredx 1st filed confidentially with the SEC Nov. 12, according to regulatory filings. The company said it plans to list on the NASDAQ exchange under the REDX symbol.
It’s the 2nd IPO in as many weeks in the medical device space, helping to cap off a hot year for medtech public flotations. Last week Asante Solutions, which makes a modular insulin pump system, registered for a $45 million IPO.
